<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="372153">
  <stage>Registered</stage>
  <submitdate>12/01/2017</submitdate>
  <approvaldate>30/01/2017</approvaldate>
  <actrnumber>ACTRN12617000160336</actrnumber>
  <trial_identification>
    <studytitle>The effects of magnesium on blood vessel function</studytitle>
    <scientifictitle>Effects of a diet that includes consuming a magnesium supplement on endothelial function</scientifictitle>
    <utrn>None</utrn>
    <trialacronym>None</trialacronym>
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Endothelial function</healthcondition>
    <healthcondition>heart disease</healthcondition>
    <conditioncode>
      <conditioncode1>Diet and Nutrition</conditioncode1>
      <conditioncode2>Other diet and nutrition disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Other cardiovascular diseases</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Magnesium supplements will be used, 400 mg/day for men and 300 mg/day for women
Participants will be provided with supplements by a researcher at a face to face visit to the University of South Australia
Participants will be asked to take the supplements as a oral tablet each day for 7 days
There is no washout period.
Participants will be asked to return any unused supplements</interventions>
    <comparator>Magnesium supplements compared with no supplements</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Ultra sound measurement of flow mediated dilatation of the brachial artery which is an accepted measure of endothelial function</outcome>
      <timepoint>after 1 week on supplements and 1 week of no supplements</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Magnesium concentration in urine</outcome>
      <timepoint>at baseline and after 1 week on supplements and 1 week on no supplements</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>BMI greater than or equal to 18 kg/m2 and less than or equal to 30 kg/m2 
Systolic BP less than or equal to 140mmHg Diastolic BP less than or equal to 90mmHg
Without self reported cardiovascular liver or kidney disease</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>70</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>BMI &lt;18 and &gt;30kg/m2 
Systolic BP &gt;140mmHg Diastolic BP &gt;90mmHg
Self reported cardiovascular liver or kidney disease
Taking medications that affect endothelial function e.g. sildenafil (Viagra)</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Allocation conducted ny another member of the research team</concealment>
    <sequence>Computerised sequence generation</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Repeated measures analysis of variance will be used to determine between group differences</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>13/02/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>30/06/2017</anticipatedenddate>
    <actualenddate />
    <samplesize>35</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>31/07/2017</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>SA</recruitmentstate>
    <postcode>5000 - Adelaide</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>University of South Australia </primarysponsorname>
    <primarysponsoraddress>School of Pharmacy and Medical Sciences, 
University of South Australia 
City East Campus 
Postal address: GPO Box 2471 Adelaide SA 5000 </primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of South AUstralia</fundingname>
      <fundingaddress>School of Pharmacy and Medical Sciences, 
University of South Australia 
City East Campus 
Postal address: GPO Box 2471 Adelaide SA 5000 </fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Heart disease is a major cause of death and disability in Australia. We have already shown that diet has a key role to play in maintaining blood vessel health. A low magnesium diet is emerging as a risk factor for heart disease and is associated with an increased risk of fatal and nonfatal ischaemic heart disease. Few studies have examined the effect of Mg on endothelial function in healthy adults. The hypothesis is that an improvement blood vessel function measured by flow mediated dilatation after a high magnesium diet achieved using dietary supplements.  </summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>HREC University of South Australia</ethicname>
      <ethicaddress>University of South Australia 

Postal address: GPO Box 2471 Adelaide SA 5000   IPC CEA 19
</ethicaddress>
      <ethicapprovaldate>12/12/2016</ethicapprovaldate>
      <hrec>Ethics Protocol 0000035834</hrec>
      <ethicsubmitdate>19/09/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>A/Prof</title>
      <name>Jennifer Keogh</name>
      <address>School of Pharmacy and Medical Sciences, University of South Australia 
Office: P1-23 Playford Building City East Campus 
Postal address: GPO Box 2471 Adelaide SA 5000
</address>
      <phone>+61 8 83022579</phone>
      <fax>+61 8 8302 2389</fax>
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Jennifer Keogh</name>
      <address>School of Pharmacy and Medical Sciences, University of South Australia 
Office: P1-23 Playford Building City East Campus 
Postal address: GPO Box 2471 Adelaide SA 5000</address>
      <phone>+61 8 83022579</phone>
      <fax>+61 8 8302 2389</fax>
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Jennifer Keogh</name>
      <address>School of Pharmacy and Medical Sciences, University of South Australia 
Office: P1-23 Playford Building City East Campus 
Postal address: GPO Box 2471 Adelaide SA 5000</address>
      <phone>+61 8 83022579</phone>
      <fax>+61 8 8302 2389</fax>
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>A/Prof</title>
      <name>Jennifer Keogh</name>
      <address>School of Pharmacy and Medical Sciences, University of South Australia 
Office: P1-23 Playford Building City East Campus 
Postal address: GPO Box 2471 Adelaide SA 5000</address>
      <phone>+61 8 83022579</phone>
      <fax>+61 8 8302 2389</fax>
      <email>jennifer.keogh@unisa.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>